Navigation Links
Heartworm Disease Prevention Protects Pets, Wallets
Date:11/19/2008

BATAVIA, Ill., Nov. 19 /PRNewswire/ -- The American Heartworm Society strongly urges pet owners to continue year-round heartworm prevention medication for their pets. It's important not to cut back on preventatives as failing to administer them could cause harm to pets, and could actually increase the financial burden if heartworm disease treatment is needed. The warning comes as this year's increase in precipitation, widespread flooding across the country and surge of hurricanes has greatly increased the mosquito population. An increased mosquito population creates a greater potential for heartworm disease, even in indoor dogs and cats.

"As the United States economy continues to struggle, we as Americans closely inspect our monthly spending for what is and isn't necessary. It's tempting to cut preventative heartworm care for pets, but the cost of prevention is still relatively low compared to the cost of treatment if heartworm disease is diagnosed. Both dogs and cats may needlessly suffer and possibly die from this completely preventable disease. The risk from the increased mosquito population makes the need for prevention even greater this year," says Dr. Sheldon Rubin, American Heartworm Society president and Chicago area practitioner.

While there is no approved treatment for feline heartworm disease, it is easily prevented. The clinical presentation of feline heartworm disease has recently been redefined as Heartworm Associated Respiratory Disease (HARD), an infection that can often lead to severe lung disease and sudden death. HARD is defined as such because heartworm disease may appear as respiratory signs which have frequently been misdiagnosed as feline asthma or allergic bronchitis. Through the KNOW Heartworms campaign, http://www.knowheartworms.org, the American Heartworm Society has partnered with the American Association of Feline Practitioners and Pfizer Animal Health to educate veterinarians and cat owners about this preventable disease.

While heartworm disease treatments are available for canines, the process of treating an infected dog is much more costly and dangerous than preventative measures. The treatment consists of a series of injections with a drug called melarsomine. The process is often painful and sometimes risky for the animal. Depending on the severity of the disease, the expense of treatment can run into many thousands of dollars.

Informational brochures, both canine and feline, are available from the American Heartworm Society, and generously provided by an educational grant from Pfizer Animal Health. They are also available from veterinarians. Visit the Society's web site at http://www.heartwormsociety.org for further information.

The American Heartworm Society, headquartered in Batavia, Illinois, is the global resource for the prevention, diagnosis and treatment of heartworm disease and was formed during the Heartworm Symposium of 1974. The American Heartworm Society stimulates and financially supports research, which furthers knowledge and understanding of the disease.

     Lea-Ann Germinder, APR, Fellow PRSA
     lgerminder@germinder.com
     816-213-8238
     816-822-0192

     Eve C. Larocca
     info@heartwormsociety.org
     American Heartworm Society
     630-262-1997

'/>"/>
SOURCE The American Heartworm Society
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. American Heartworm Society Announces Heartworm Incidence Survey
2. China Documents First Case of Tick-Borne Disease Spread
3. New approach to screen individuals for early Alzheimers disease
4. Primate disease field guide covers critical gap in global health
5. Crohns disease surgeries make steady advances
6. Hepatitis C Therapeutic DNA Vaccine Delivered by Inovio Biomedical's Electroporation Technology Reduces Viral Load by Up to 99.7% : Clinical Data Presented at Annual Scientific Meeting of the American Association for the Study of Liver Diseases
7. Conference report highlights new research into drug delivery to treat eye disease
8. Applying supply and demand business principles to treat infectious diseases worldwide
9. Money motivates doctors to reduce ethnic differences in heart disease treatments
10. New Evidence Found for CRP as an Independent Marker for Heart Disease, Stroke
11. Substance in Red Grapes and Wine Key to Alzheimer's Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of ... its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his ... July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes , ... mock evacuation of the facility as part of a disaster drill on October 3rd. ... EMS and Shelton City Emergency Manager, as well as the Connecticut Long Term ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released ... understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture ... Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that is ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
(Date:10/12/2017)... ... 2017 , ... The American College of Medical Informatics (ACMI) will present the ... Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... a pioneer in the field of medical informatics, this prestigious award is presented to ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
(Date:9/22/2017)... 22, 2017 AVACEN Medical (AVACEN) announced that ... successfully helping those with the widespread pain associated with ... Amanda in Essex, England commented, ... hair, experiencing no sleep at all, tremendous pain, with ... cannot recommend [the AVACEN 100] enough, how this has ...
Breaking Medicine Technology: